Literature DB >> 29057060

Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines.

Masahito Abe1,2, Mabel Seto1,2, Rocco G Gogliotti1,2, Matthew T Loch1,2, Katrina A Bollinger2, Sichen Chang2, Eileen M Engelberg1,2, Vincent B Luscombe1,2, Joel M Harp3, Michael Bubser1,2, Darren W Engers1,2, Carrie K Jones1,2,4, Alice L Rodriguez1,2, Anna L Blobaum1,2, P Jeffrey Conn1,2,4, Colleen M Niswender1,2,4, Craig W Lindsley1,2,4.   

Abstract

Herein, we report the structure-activity relationships within a series of mGlu7 PAMs based on a pyrazolo[1,5-a]pyrimidine core with excellent CNS penetration (Kps > 1 and Kp,uus > 1). Analogues in this series proved to display a range of Group III mGlu receptor selectivity, but VU6005649 emerged as the first dual mGlu7/8 PAM, filling a void in the Group III mGlu receptor PAM toolbox and demonstrating in vivo efficacy in a mouse contextual fear conditioning model.

Entities:  

Keywords:  Positive allosteric modulator (PAM); Rett syndrome; VU6005649; cognition; metabotropic glutamate receptor 7 (mGlu7)

Year:  2017        PMID: 29057060      PMCID: PMC5641958          DOI: 10.1021/acsmedchemlett.7b00317

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

1.  Lack of the metabotropic glutamate receptor subtype 7 selectively modulates Theta rhythm and working memory.

Authors:  Christian Hölscher; Susanne Schmid; Peter K D Pilz; Gilles Sansig; Herman van der Putten; Claudia F Plappert
Journal:  Learn Mem       Date:  2005 Sep-Oct       Impact factor: 2.460

2.  A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.

Authors:  Emmanuel Le Poul; Christelle Boléa; Francoise Girard; Sonia Poli; Delphine Charvin; Brice Campo; Julien Bortoli; Abdhelak Bessif; Bin Luo; Amy Jo Koser; Lisa M Hodge; Karen M Smith; Anthony G DiLella; Nigel Liverton; Fred Hess; Susan E Browne; Ian J Reynolds
Journal:  J Pharmacol Exp Ther       Date:  2012-07-11       Impact factor: 4.030

Review 3.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

4.  Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice.

Authors:  Hannelore Goddyn; Zsuzsanna Callaerts-Vegh; Stijn Stroobants; Trinette Dirikx; Debora Vansteenwegen; Dirk Hermans; Herman van der Putten; Rudi D'Hooge
Journal:  Neurobiol Learn Mem       Date:  2008-03-04       Impact factor: 2.877

5.  Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population.

Authors:  Wenjin Li; Kang Ju; Zhiqiang Li; Kuanjun He; Jianhua Chen; Qingzhong Wang; Beimeng Yang; Lin An; Guoyin Feng; Weiming Sun; Juan Zhou; Shasha Zhang; Pingping Song; Raja Amjad Waheed Khan; Weidong Ji; Yongyong Shi
Journal:  Eur Neuropsychopharmacol       Date:  2015-05-27       Impact factor: 4.600

6.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

7.  Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7.

Authors:  Trevor J Bushell; Gilles Sansig; Valerie J Collett; Herman van der Putten; Graham L Collingridge
Journal:  ScientificWorldJournal       Date:  2002-03-15

8.  Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

Authors:  S I Shyn; J Shi; J B Kraft; J B Potash; J A Knowles; M M Weissman; H A Garriock; J S Yokoyama; P J McGrath; E J Peters; W A Scheftner; W Coryell; W B Lawson; D Jancic; P V Gejman; A R Sanders; P Holmans; S L Slager; D F Levinson; S P Hamilton
Journal:  Mol Psychiatry       Date:  2009-12-29       Impact factor: 15.992

9.  Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7.

Authors:  Nidhi Jalan-Sakrikar; Julie R Field; Rebecca Klar; Margrith E Mattmann; Karen J Gregory; Rocio Zamorano; Darren W Engers; Sean R Bollinger; C David Weaver; Emily L Days; L Michelle Lewis; Thomas J Utley; Miguel Hurtado; Delphine Rigault; Francine Acher; Adam G Walker; Bruce J Melancon; Michael R Wood; Craig W Lindsley; P Jeffrey Conn; Zixiu Xiang; Corey R Hopkins; Colleen M Niswender
Journal:  ACS Chem Neurosci       Date:  2014-10-09       Impact factor: 4.418

10.  Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder.

Authors:  Radhika Kandaswamy; Andrew McQuillin; David Curtis; Hugh Gurling
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-05-08       Impact factor: 3.568

View more
  7 in total

1.  Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound.

Authors:  Carson W Reed; Jacob J Kalbfleisch; Madison J Wong; Jordan P Washecheck; Ashton Hunter; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

2.  VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides.

Authors:  Carson W Reed; Kevin M McGowan; Paul K Spearing; Branden J Stansley; Hanna F Roenfanz; Darren W Engers; Alice L Rodriguez; Eileen M Engelberg; Vincent B Luscombe; Matthew T Loch; Daniel H Remke; Jerri M Rook; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2017-11-08       Impact factor: 4.345

3.  Synthesis and SAR of a series of mGlu7 NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core.

Authors:  Jacob J Kalbfleisch; Carson W Reed; Charlotte Park; Paul K Spearing; Marc C Quitalig; Matthew T Jenkins; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2020-09-02       Impact factor: 2.823

4.  Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms.

Authors:  Hongzhao Wang; Zijian Qin; Aixia Yan
Journal:  Mol Divers       Date:  2021-02-03       Impact factor: 3.364

Review 5.  Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.

Authors:  Nicole M Fisher; Mabel Seto; Craig W Lindsley; Colleen M Niswender
Journal:  Front Mol Neurosci       Date:  2018-10-23       Impact factor: 5.639

6.  Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.

Authors:  Nicole M Fisher; Mabel Seto; Craig W Lindsley; Colleen M Niswender
Journal:  Front Mol Neurosci       Date:  2018-12-14       Impact factor: 5.639

Review 7.  Functional Pyrazolo[1,5-a]pyrimidines: Current Approaches in Synthetic Transformations and Uses As an Antitumor Scaffold.

Authors:  Andres Arias-Gómez; Andrés Godoy; Jaime Portilla
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.